Dr Gerard sp. z o.o.

Based in Poland, Dr Gerard sp. z o. o. is a baked goods manufacturer specializing in cookies, wafers, and gingerbread products, serving a wide market both domestically and internationally.

Dr Gerard sp. z o. o. specializes in producing baked goods.

Founded in 1993, the company is headquartered in Międzyrzec Podlaski, Poland. In October 2013, the company was acquired by Bridgepoint from Biscuit Holding S. A. S and LBO France.

The firm has completed two deals to date, with the latest funding round being an Add-on for EUR 100. 000 led by Biscuit International. Dr. Gerard specializes in the production of a diverse array of baked goods, primarily focusing on cookies, wafers, and gingerbread products.

Their core offerings include the popular Chococool Cream, which combines a crunchy biscuit with a smooth cream filling and rich chocolate, as well as a variety of cocoa biscuits and delicate wafers filled with velvety cocoa cream. The company aims to deliver high-quality snacks that cater to the tastes of cookie enthusiasts, capitalizing on both sweet and savory flavor profiles. Dr. Gerard products are manufactured in two locations in Poland, specifically in Międzyrzec Podlaski and Radzyń Podlaski, and are exported to over 30 countries worldwide, targeting markets in Europe and beyond.

The brand serves a broad customer base, including consumers looking for indulgent snacks, as well as retailers and wholesalers seeking reliable suppliers of high-quality baked goods. Dr. Gerard's revenue generation is supported through a multifaceted distribution strategy, which includes partnerships with retailers and wholesalers, along with direct-to-consumer sales. The company reported a revenue of EUR 134,151,034.

5 in 2023, with an EBITDA of EUR 17,013,833. 2. Their business model facilitates transactions in various forms, allowing for both bulk orders and individualized purchases. Flagship offerings such as Chococool Cream and their assorted cookies are central to their sales efforts, appealing to a wide audience looking for premium snack options.

Overall, Dr. Gerard emphasizes quality and innovation to meet the demands of a competitive market, reflecting its commitment to maintaining high standards across its product lines. Dr. Gerard is focused on developing new product lines and expanding its market presence.

The company aims to introduce innovative baked goods in the coming years and is targeting new geographic markets, particularly in Europe and Asia, for expansion by 2025. The recent funding round will support these initiatives and enhance production capabilities as the company seeks to increase its global footprint.